The Latest Cardiac and Vascular News
Topline data expected first quarter 2021 BEDMINSTER, N.J., Aug. 27, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has completed enrollment in the ENHANCE-IT Study (Pharmacodynamic Effects of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids to ENHANCE Efficacy in Adults with Hypertriglyceridemia), a […]
NILEMDO® (bempedoic acid) is a new, first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering treatment that significantly reduces LDL-C on top of statins and other lipid-lowering therapies1 Bempedoic acid acts on the well-known cholesterol synthesis pathway, upstream of the statin target in the liver1 Due to its unique mechanism of action, bempedoic […]
onnected cardiology solutions help physicians elevate clinical confidence, improve patient and staff experience, and improve outcomes Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest cardiac care innovations at the European Society of Cardiology ESC Congress 2020 (August 29 – September 1). During […]
Minimally invasive treatment revolutionized cardiac medicine, replacing open-heart surgery for many patients CHICAGO, Aug. 26, 2020 /PRNewswire/ — Northwestern Medicine Bluhm Cardiovascular Institute physicians recently completed their 2000th transcatheter heart valve procedure, a milestone innovation that has shifted valve repair and replacement from operating room to catherization lab, dramatically reducing procedural time, recovery […]
Repatha (Evolocumab) Late-Breaking Data Showcase First Phase 3 Study of a PCSK9 Inhibitor in Pediatric Heterozygous Familial Hypercholesterolemia New Data Highlight Gaps in Treating High LDL-C to Clinical Treatment Guidelines in a Large Cohort of European, High-Risk CVD Patients THOUSAND OAKS, Calif., Aug. 25, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced the […]
Revised Commercial Labeling Broadens Patient Population Who May be Candidates for Transcatheter Aortic Valve Replacement (TAVR) DUBLIN, Aug. 21, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) has approved revised commercial labeling for the Evolut™ TAVR platform […]
WINNIPEG, MB, Aug. 24, 2020 /PRNewswire/ – Medicure Inc. (“Medicure” or the “Company“) (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, is reporting that early investigator sponsored clinical reports evaluating the efficacy of AGGRASTAT® (tirofiban hydrochloride) show promise for preventing and treating thrombotic complications due to COVID-19. AGGRASTAT® is not currently indicated for use in patients with COVID-19. […]
First and Only Technology Providing Continuous Real-Time Alerting of Heart Attacks SINGAPORE–(BUSINESS WIRE)–Jasper Capital Ltd www.jasperCL.com (“Jasper”), a private equity fund with operations in Singapore and Silicon Valley, today announced the first successful implant of an implantable commercial heart attack alarm system, called the Guardian® system, developed by its portfolio company, Angel […]
Now one of the largest and strongest pediatric cardiovascular programs in the country MINNEAPOLIS, Aug. 18, 2020 /PRNewswire/ — Children’s Minnesota and Mayo Clinic announced today that they have reached the next phase of an agreement to collaborate in the care of children with congenital heart disease. This phase of the agreement adds pediatric […]
EATONTOWN, N.J., Aug. 18, 2020 /PRNewswire/ — Key Highlights: First AngelMed Guardian® patient implants in Asia Pacific for Hydrix Medical, a subsidiary of Hydrix Limited (ASX: HYD) Four implants were carried out under the guidance of leading Cardiologist Dr. Leslie Lam This significant milestone provides a foundation for future implants under early access schemes in Singapore and Australia Angel […]
